STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Clinical trials for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Three-Pronged attack tested for aggressive lung cancer
Disease control OngoingThis early-stage study is testing if a three-part treatment plan is safe and feasible for people with operable pleural mesothelioma, a cancer often linked to asbestos exposure. The plan involves chemotherapy plus an immunotherapy drug before surgery, followed by up to a year of t…
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 18:41 UTC
-
New drug combo tested against rare, Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, atezolizumab and bevacizumab, can help control several rare types of advanced solid tumors. The trial is for adults whose cancer has spread or returned after other treatments. The goal is to see if this drug …
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC